Product Information

ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.7413 per ML under NDC 63323069030. Its NADAC has been published 573 times since Nov 28, 2013.

FDA first approved this application on Jun 21, 2012. Its Orange Book therapeutic-equivalence code is AN.

ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)

ACETYLCYSTEINE
$0.7413per ML

Strength

200 mg/mL

NDC

63323069030

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL; RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Active Ingredients

ACETYLCYSTEINE

Approval Type

Generic (ANDA)

FDA Application

ANDA203853

FDA Approved

6/21/2012

TE Code

AN

On Market Since

9/1/2012

Pharmacological Classes

Antidote
Antidote for Acetaminophen Overdose
Decreased Respiratory Secretion Viscosity
Increased Glutathione Concentration
Mucolytic
Reduction Activity

Price Statistics

The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 573 times since Nov 28, 2013, and over the history we have for it it has risen 135.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7413 per ML
All-time high$0.7751 (Aug 14, 2024)
All-time low$0.2303 (Feb 19, 2014)
52-week high$0.7447
52-week low$0.6011
Median price$0.3333
Average price$0.4033
Largest weekly change+108.4% (Apr 17, 2024)
Weeks tracked573
Tracking sinceNov 28, 2013

Price History

1W

-0.5%

1M

-0.5%

3M

+5.8%

6M

+3.0%

1Y

+23.3%

3Y

+104.6%

5Y

+104.6%

All

+135.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by Fresenius Kabi USA, LLC, is $0.7413 per ML (NDC 63323069030), effective Aug 19, 2026.

How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?

Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has risen 135.2%. It has been tracked across 573 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

Since Nov 28, 2013, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $0.2303 (Feb 19, 2014) to a high of $0.7751 (Aug 14, 2024), with a median of $0.3333 per ML.

Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) in a comparable dosage form, but none are currently priced below it.

Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 63323069030) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.